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1. Introduction
Nowadays, sexually transmitted infections (STIs) still 
remain a major global health problem with about 1 mil-
lion of new cases of chlamydia, gonorrhea, trichomo-
niasis or syphilis daily [55]. However, in 2017 the World 
Health Organization qualified Neisseria gonorrhoeae, as 
the only etiological agent of STIs, among the “priority 
pathogens” that pose the greatest threat to human health 
because of antibiotic resistance [54]. In 2012, an esti-
mated 78 million new cases of gonorrhea caused by an 
obligatory human pathogen N. gonorrhoeae (gonococ-
cus), occurred among 15–45 year-old patients world-
wide [16, 55]. Gonococci infect a diverse array of human 
mucosal surfaces, although the most common place of 
infection is the genitourinary tract [17]. Infection with 
N. gonorrhoeae leads to acute urethritis in men and cer-
vicitis in women, which in 50–80% cases is asympto-
matic [10]. Untreated gonor rhea may result in serious 
complications in women such as pelvic inflammatory 
disease (PID), ectopic pregnancy and infertility [16].
The crucial challenge related to gonorrhea treatment 
is increased multi-drug resistance of N. gonorrhoeae 
[54]. What is more, there are problems with construct-
ing an effective vaccine due to the highly antigenically 
variable surface of these bacteria and lack of appro-
priate animal model of this disease, with the exception 
of chimpanzees [20, 26]. Additionally, infection with 
N. gonorrhoeae does not induce protective immunity 
[12]. Hence it is crucial to understand the mechanisms 
underlying the ability of gonococci to avoid the first 
line defence in the human host, which is the innate 
immune response [26]. 
2. Adherence ability
One of the main function of the surface structures 
of gonococci – Opacity-associated proteins (Opa), as 
virulence factors, is their involvement in attachment to 
human cells during mucosa infection which facilitates 
affective colonization. Different Opa proteins can inter-
act with different hosts receptors, for example, human 
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carcinoembryonic antigen-related cell adhesion mole-
cules (CEACAMs): CEACAM1, CEACAM3, CEACAM5 
and CEACAM6 as well as heparan sulfate proteoglycans 
(HSPGs) or integrins [36]. CEACAM1 and CEACAM6 
have several functions, for example, in cell adhesion and 
angiogenesis, and are expressed in different cell types. 
CEACAM3, on the contrary, is expressed in neutrophils 
only and functions primarily as a receptor for Gram-
negative, human-restricted pathogens like N. gonor­
rhoeae and Neisseria meningitidis. Variations in the 
binding properties of Opa proteins are caused by dif-
ferences in the sequence of their extracellular loops [2]. 
Interaction of N. gonorrhoeae with CEACAMs proteins 
expressed on the surface of epithelial cells facilitates 
bacterial adhesion to host cells and can trigger engulf-
ment and transcytosis through epithelial cells which 
can lead to further dissemination of the infection [37, 
43]. It is commonly known that intracellular bacteria 
can alter the host’s immune response [49]. It has been 
demonstrated that N. gonorrhoeae induces tyrosine 
phosphorylation of epidermal growth factor receptor 
(EGFR), what is an essential step prior to invasion and 
is able to escape autophagy-mediated killing in human 
epithelial cells by activating the autophagy repressor 
mammalian target of rapamycin complex 1 (mTORC1) 
[27, 48]. Interestingly, a lack of Opa proteins increases 
transmigration across epithelial cells [45].
3. Serum resistance and complement system 
The bactericidal function of human serum depends 
mostly on the interaction of IgM antibodies with patho-
genic bacteria and the further complement-mediated 
killing of sensitive strains [7]. However, complement 
activation may occur by 3 different pathways: i) classi-
cal, due to the presence of an antigen-antibody complex; 
ii) alternative, related to interaction with the surface of 
the pathogen; iii) lectin, based on interactions between 
soluble pattern recognition molecules (Mannose‐bind-
ing lectin (MBL), collectin‐10, collectin‐11 and ficolins) 
and microbial surface [32, 13]. Activation of these path-
ways leads to C3-convertase activation, which performs 
an essential effector function in the whole complement 
cascade and results in, for example, C3b deposition on 
the bacterial surface, which enables phagocytic cells to 
internalize the pathogen, inflammation to progress due 
to C3a and C5a activity and a Membrane Attack Com-
plex (MAC) to form that eradicates the bacteria directly 
[19, 32]. However, efficient complement deposition on 
most pathogenic bacteria requires the initiation of com-
plement activation via the classical pathway [4]. 
It is generally considered that the complement sys-
tem plays a crucial role in an innate immune response 
against N. gonorrhoeae: patients with a deficiency of 
complement components are more susceptible to dis-
seminated gonococcal infections (DGI) [30]. N. gonor­
rhoeae mainly activates the classical complement 
pathway and gonococci isolated from the female geni-
tourinary tract are coated with complement compo-
nents [18, 29]. However, gonococci possesses an arsenal 
of mechanisms that enable this pathogenic bacteria to 
evade complement-mediated killing. 
The most common location of gonococcal infec-
tion is the mucosa of the female and male genitourinary 
tract [17]. It has been demonstrated that N. gonorrhoeae 
freshly isolated from the place of infection is mostly 
characterized by resistance to the normal human serum 
(NHS), and that this resistance is lost during the cultiva-
tion period [53]. On the basis of gonococcal resistance 
to NHS, N. gonorrhoeae in a population are divided into 
serum-sensitive and serum-resistance bacteria [34]. 
Serum-sensitive gonococci mainly cause local infections 
with symptoms of inflammation while the presence of 
serum-resistance bacteria is related to the disseminated 
gonococcal infection [31]. The serum-resistance pheno-
type is maintained by sialylation of lacto-N-neotetra-
ose (LNT) of gonococcal lipooligosaccharide (LOS) 
by 5-cytidinemonophospho-N-acetylneuraminic acid 
(CMP-NANA) acquired by N. gonorrhoeae from its 
human host [28]. This modification decreases antibody 
binding and prevents complement-dependent killing of 
the bacteria by human sera. This phenomenon is called 
“unstable” serum-resistance, because the loss of LOS 
sialylation leads to a serum-sensitive phenotype [9]. 
It has been demonstrated that the resistance to NHS 
featured by gonococci with sialylated LOS is related 
to the ability of this bacteria to bind to factor H (fH) 
(Figure 1) [41]. Factor H is a complement regulatory 
protein, which inhibits the complement alternative path-
way by, for example, being a cofactor for the cleavage 
of C3b to hemolytically inactive iC3b and acceleration 
of C3-convertase decay [52]. However, the bactericidal 
potential of some domains of this protein has also been 
demonstrated in vitro [40]. Another analysis revealed 
that interaction of sialylated LOS with fH is influenced 
by porin (Por) proteins of N. gonorrhoeae [28]. Por1A 
and Por1B proteins represent up to 60% of all surface 
proteins of N. gonorrhoeae and they function as selec-
tive anion channels. These two major allelic isoforms 
of gonococcal porin proteins undergo an equable anti-
genic variation [31]. Por1A strains are more likely to 
cause DGI, without symptoms of local inflammation 
and those gonococci expressing Por1B protein are more 
related to local genital tract infection and PID [1]. The 
reason of such a variation of symptoms between these 
two isoforms is the difference in the ability of Por1A 
and Por1B expressing gonococci to bind fH: most Por1A 
proteins can bind to fH and Por1B proteins bind to 
fH weakly, unless gonococcal LOS is sialylated [41]. 
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Additionally, despite its function as an alternative path-
way inhibitor, fH also enhances the adhesion and inva-
sion of N. gonorrhoeae to cervical cells through Comple-
ment Receptor 3 (CR3). It has been demonstrated that 
Por1A-expressing gonococci invade CR3-expressing 
cells with greater efficiency than Por1B strains and this 
may be the reason why Por1A strains mostly cause dis-
seminated disease with no signs of inflammation [1].
Another complement regulatory protein that is used 
by gonococci to evade complement mediated killing is 
C4b-binding protein (C4BP). This big serum protein 
can alter all three complement pathways thus inhibiting 
opsonization and killing by phagocytic cells, and Por1A 
and certain Por1B strains are able to interact with this 
protein. Interaction between Por proteins and C4BP 
protein is strongly correlated with serum resistance 
phenotype, as it is demonstrated for fH protein [19].
4. Neutrophils
N. gonorrhoeae, during colonization of the urogeni-
tal tract mucosa, release pathogen-associated molecular 
patterns (PAMPs), that activate, for example, toll-like 
receptor  2 (TLR2), toll-like receptor 4 (TLR4) and 
nucleotide-binding oligomerization domain 1 (NOD1) 
[8, 33]. As a consequence, the nuclear factor kappa-
lightchain-enhancer of activated B cells (NF-ĸB) is 
activated in epithelial cells and immune cells residing 
in infected tissue, which results in up-expression and 
further secretion of many proinflammatory cytokines 
and chemokines including interleukin 8 (IL-8) [33, 46]. 
This chemokine acts as a chemoattractant to polymor-
phonuclear leukocytes (PMNs, neutrophils) circulat-
ing in the bloodstream and guides them to the place of 
infection [46]. In infected tissue, the effective response 
of PMNs toward pathogenic bacteria depends on: 
phagocytosis, production of neutrophil extracellular 
traps (NETs) and degranulation of neutrophils, with 
the involvement of oxygen-dependent and oxygen-
independent mechanisms [3]. 
Clinical symptoms of gonococcal infection are 
mainly caused by infiltration of these immune cells. 
However, it has been demonstrated that N. gonorrhoeae 
is able to survive within PMNs isolated from the site of 
infection and has evolved many mechanisms to evade 
neutrophil mediated killing [38] (Figure 2). 
4.1. Phagocytosis
Interaction of particular Opa proteins with PMNs 
CEACAMs (CEACAM1, CEACAM3 and CEACAM6) 
leads to more efficient phagocytosis of this bacteria by 
neutrophils in comparison to Opaless gonococci, even 
without opsonization by complement or antibodies 
[2]. Furthermore, engulfment of N. gonorrhoeae via 
CEACAM1 and CEACAM6 results in weak activation 
of PMNs in comparison to CEACAM3-related internal-
ization, which also activates proinflammatory response 
in these cells. As previously mentioned, gonococci have 
a major advantage when interacting with CEACAMs 
on epithelial cells, but Opa expressing N. gonorrhoeae 
are threatened by CEACAM3-expressing neutrophil 
killing [37]. PMNs activation results in degranulation 
and oxidative burst, ending in tissue damage, which 
can help N. gonorrhoeae to colonize the deeper layer of 
epithelia [22, 38]. The same effect is observed during 
the infiltration of new PMNs that are attracted from the 
bloodstream by neutrophils that has already internal-
ized N. gonorrhoeae and activated their proinflamma-
tory response [43]. Therefore, it is postulated that a bal-
ance between Opaless and Opa-positive gonococci is 
a strategy that enable these bacteria to sequentially and 
effectively undergo different stages of infection [22].
4.1.1. Oxygen-dependent intracellular killing
During phagocytosis, PMNs are able to eradicate 
bacteria by oxygen-dependent and oxygen-independ-
ent mechanisms. During the process called oxidative 
burst, activation of nicotinamide adenine dinucleotide 
Fig. 1. Diagram of the complement system inhibition by N. gonor-
rhoeae [according to 13, 19, 32, 41, 52]. Por1A – porin 1A; Por1B 
– porin 1B; fH – factor H; fI – factor I, C4BP – C4b-binding protein; 
LOS – lipooligosaccharide.
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phosphate (NADPH) oxidase in neutrophils sequen-
tially leads to the generation of numerous reactive 
oxygen species (ROS) such as hydrogen peroxide or 
hydrochloric acid [38]. N. gonorrhoeae features multiple 
mechanisms that protect this bacterium from oxida-
tive stress. It has been demonstrated that incubation of 
N. gonorrhoeae with sub-lethal concentrations of hydro-
gen peroxide results in changes of expression of more 
than 150 genes, including those encoding superoxide 
dismutase and cytochrome c peroxidase, known anti-
oxidant agents [47]. However, it has also been demon-
strated that strains deficient in oxidative stress defence 
molecules are sensitive to killing by PMNs at the same 
level as wild type strains [38]. Furthermore, neutro-
phils from patients with chronic granulomatous disease 
(CGD), who are deficient in NADPH oxidase, still pos-
sesses the ability to kill N. gonorrhoeae [42]. 
It is worth mentioning that the other aspect of ROS 
production is related to N. gonorrhoeae phenotype. One 
of the surface structures of gonococci that modulates 
the interaction with human cells are Opa [37]. N. gon­
orrhoeae possesses at least 12  opa loci and encoding 
11 Opa proteins [36]. Expression of Opa undergoes fre-
quent phase variation, also during experimental male 
infection, so the gonococci in a population differ in Opa 
protein phenotype. Opa-negative (Opaless) gonococci 
are unable to induce ROS production in PMNs due 
to the ability to limit assembly of NADPH oxidase in 
the neutrophil membrane, in contrast to Opa-positive 
strains that stimulate the formation of this enzyme [44]. 
Furthermore, they also suppress oxidative burst caused 
by other stimuli such as serum-opsonized Staphylococ­
cus aureus [2]. Suppression of oxidative burst may be 
a huge survival advantage for this bacterium and may 
also be connected to differences in the course of infec-
tion between men and women. Opaless phenotype is 
more predominant in women and can contribute to 
asymptomatic infection [44]. Thus, the Opa pheno-
type strictly facilitates the evasion of oxygen-dependent 
mechanisms by N. gonor rhoeae, although this protein 
also contributes to the protection to oxygen-independ-
ent mechanisms.
4.1.2. Oxygen-independent intracellular killing
It is therefore postulated that the oxygen-inde-
pendent mechanisms are more significantly related to 
destroying the subset of N. gonorrhoeae that are sensi-
tive to PMNs killing and that the survival advantage 
of some of gonococci results from an ability to evade 
these mechanisms [38]. While evading non-oxidative 
mechanisms, gonococci are able to delay the fusion of 
phagosomes with primary granules within PMNs, while 
maintaining fusion with tertiary and secondary gran-
ules [23]. The delayed fusion between phagosome and 
primary granules results in the delayed contact of gono-
cocci with the antimicrobial content of these granules 
(BPI) [5, 39]. However, it has been demonstrated that 
the N. gonorrhoeae LptA mutant is more susceptible to 
killing by non-oxidative components of primary gran-
ules including cathepsin G than the wild-type strain, so 
LptA contributes to the protection of gonococci against 
this protein. Interestingly, N. gonorrhoeae that expresses 
LptA also decreases the maturation of phagosomes, 
while LptA deficient gonococci are more frequently 
found in primary granule-positive phagolysosomes 
[15]. Thus it is postulated that LptA is an important 
virulence factor that contributes to the adaptation to 
mechanisms of the host immune response and ensures 
the survival advantage of N. gonorrhoeae [15, 23].
Fig. 2. Evading of neutrophil-mediated killing by N. gonorrhoeae [according to 3, 6, 15, 25, 33, 44]. LptA – LOS phospho-
ethanolamine transferase A; Nuc – thermonuclease homolog; LtgA – lytic transglycosylase A; LtgD – lytic transglycosylase D.
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4.2. Neutrophil extracellular traps
One of the mechanisms that is utilized by neutro-
phils to destroy pathogenic bacteria is the formation 
of NETs, which are mesh-like structures composed 
of chromatin and antimicrobial granule components 
of PMNs, and can be produced by dying neutrophils, 
during the cell death process called NETosis, or by live 
cells [50, 25]. The extrusion of NETs to an extracellular 
matrix, in order to trap microbes, prevents pathogen 
dissemination as well as being able to activate other 
immune cells [3]. NETs production by neutrophils is 
thought to depend on oxidative burst and require mye-
loperoxidase (MPO) [14]. However, it has been demon-
strated that N. gonoorhoeae has the ability to stimulate 
PMNs to produce NETs through oxygen-independent 
mechanisms too. Interestingly, common surface anti-
gens of gonococci – OpaD protein and pili – reinforce 
the stimulation of NETs production in neutrophils but 
are not required for this process. Nevertheless, NETs 
produced by neutrophils are unable to kill N. gonor­
rhoeae in vitro, unless the gonococci have a OpaD-pos-
itive and nonpiliated phenotype and are internalized by 
PMNs. The authors suggest that the elimination of this 
bacteria is related to oxidative burst, as the presence 
of an inhibitor of the NADPH oxidase in PMNs with 
internalized OpaD-positive and nonpiliated N. gonor­
rhoeae prevent the killing of this bacteria. As NETs are 
capable of killing Lactobacillus crispatus, which is one 
of the most predominant commensal bacteria of the 
women’s genitourinary tract, it is possible that reduced 
competition facilitates the colonization of infected 
niche by N. gonorrhoeae [14, 51]. 
A thermonuclease homolog (Nuc) encoded by 
N. gonor rhoeae is a protein involved in biofilm reor-
ganization by the degradation of DNA. Furthermore, it 
also enhances the survival of gonococci in the presence 
of NETs. It has been demonstrated that recombinant 
Nuc is able to degrade DNA present in NETs, therefore 
facilitating the weakening of these structures’ integrity. 
Thus, this protein is considering as a virulence factor of 
gonococci that can defend these bacteria against extra-
cellular killing by neutrophils [25].
Another gonococcal protein that facilitates bacte-
rial survival in the presence of NETs is LOS phospho- 
 ethanolamine transferase A (LptA), which is a phase-
variable enzyme that catalyzes the addition of phos-
phoethanolamine (PEA) to 4’ phosphate on lipid  A. 
This enzymatic modification of the LOS component 
by LptA results in less killing of N. gonorrhoeae by 
NETs produced by PMNs, in comparison to gono-
cocci without this modification. This process may 
occur due to the fact that N. gonorrhoeae mutant in the 
gene encoding LptA protein is more sensitive to the 
serine protease cathepsin G, which is also a compo-
nent of NETs, compared to the wild-type strain [15, 
11]. Interestingly, it has also been demonstrated that 
a lack of 4’ PEA modification in lipid A in most com-
mensal Neisseria species decreases inflammatory 
response towards these bacteria in human monocytes, 
thus contributing to the immune privilege of these 
strains [21]. Surprisingly, it is postulated that the acti-
vation of the proinflammatory response by gonococci 
may be favourable to them, because N. gonorrhoeae 
is able to avoid most of the mechanisms of the innate 
immune response and may use damaged tissue as 
a source of nutrients and a way to colonize deeper lay-
ers of the epithelia [15]. 
4.3. Degranulation
Production of NETs is not the only mechanism by 
which neutrophils combat N. gonorrhoeae extracellu-
larly. During the process called degranulation, neutro-
phil’s granules fuse with the cytoplasmic membrane and 
release antimicrobial molecules including, for example, 
cathepsin G [3, 11]. Despite the protective role of LptA 
against extracellular killing by neutrophils, gonococci 
also possess other enzymes that are involved in the 
protection against antimicrobial proteins released by 
neutrophils [15, 33]. Double mutant in genes encoding 
two lytic transglycosylases (LTs): LtgA and LtgD, which 
are involved in peptidoglycan release, is more sensi-
tive to lysozyme and neutrophil elastase than double 
complement N. gonorrhoeae. The reason is decreased 
envelope integrity in the analysed mutant. Addition-
ally, infection of the human primary neutrophils with 
N. gonorrhoeae expressing LtgA and LtgD results in 
decreased release of the neutrophil’s antimicrobial 
molecules compared to the mutant in genes encoding 
these two proteins [33]. In conclusion, N. gonorrhoeae, 
as a highly adapted human pathogen, has many factors 
that contributes to its response against the extracellular 
antimicrobial mechanism of neutrophils. 
4.4. Apoptosis
Another mechanism that N. gonorrhoeae uses to its 
own advantage is the election of an anti-apoptotic effect 
in neutrophils. This process occurs through inhibition 
of caspase-3 and suppression of effect of proapoptotic 
agents like staurosporine by N. gonorrhoeae. Due to 
the fact that infection with gonococci results in NF-ĸB 
activation and further neutrophil migration toward 
the site of infection, it is postulated that the inhibition 
of apoptosis in these cells provides a notable niche for 
the replication of gonococci in these normally short-
lived cells [6].
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5. Summary
Innate immune response is a first line of defence 
against pathogenic bacteria including N. gonorrhoeae 
[26]. However asymptomatic infections in women, 
a  lack of protective immunity observed in many 
patients and long-term complications like dissemina- 
ted gonococcal infections indicate that this patho-
gen possesses an arsenal of mechanisms to avoid this 
response [1, 10, 12]. 
As demonstrated, N. gonorrhoeae has many virulence 
factors that undergo phase and antigenic-variation and 
play a crucial role in adapting to the hostile environment 
of infected human tissues, which includes elements of 
the host’s innate immune response [31, 44, 51]. The abil-
ity of gonococci to evade complement-mediated killing 
through, for example, C4BP protein is considered to be 
the reason why this bacteria can only establish infection 
in humans and experimental infection in chimpanzees, 
which indicates that N. gonorrhoeae is a highly adapted 
human pathogen majorly through the ability to avoid 
the human innate immune response [31].
 Furthermore, N. gonorrhoeae, in contrast with many 
pathogenic microorganisms, possesses mechanisms 
(like the modification of lipid A) that boost the detec-
tion of this bacteria by the human host, thus enhancing 
inflammation [15]. However, due to the ability to evade 
both oxygen-dependent and oxygen-independent anti-
bacterial activities of PMNs, gonococci take advantage 
of the tissue degradation caused by inflammation [15]. 
Consequently, persistent gonococcal infection in the 
presence of neutrophils leads to an effective colonization 
of infected tissues and further dissemination of bacteria 
[23]. Thus, phase and antigenic-variation of many viru-
lence factors that are used by gonococci to evade com-
plement and neutrophil-mediated killing is involved in 
the overall modulation of the innate immune response 
in order to take advantage of subsequently induced 
stages of this response by N. gonorrhoeae [15, 23].
As N. gonorrhoeae is a strictly human pathogen and 
many virulence factors of this bacteria undergo phase 
and antigenic-variation, there has still been limited pro-
gress in making a gonorrhea vaccine [35]. Taking into 
account the increasing antibiotic resistance of N. gon­
orrhoeae and the absence of an effective vaccine, a full 
understanding of the mechanism underlying the modu-
lation of the host’s immune response by this pathogen 
seems to be imperative [17]. 
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